Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile

被引:18
作者
Cacciari, Barbara [3 ]
Bolcato, Chiara [1 ]
Spalluto, Giampiero [1 ]
Klotz, Karl-Norbet [4 ]
Bacilieri, Magdalena [2 ]
Deflorian, Francesca [2 ]
Moro, Stefano [2 ]
机构
[1] Univ Trieste, Dipartimento Sci Farmaceut, I-34127 Trieste, Italy
[2] Univ Padua, Dipartimento Sci Farmaceut, Mol Modeling Sect, I-35131 Padua, Italy
[3] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
[4] Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany
关键词
adenosine receptors; antagonists; binding; molecular modeling; pyrazolo-triazolo-pyrimidines;
D O I
10.1007/s11302-006-9027-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the last 5 years, many efforts have been conducted searching potent and selective human A(3) adenosine antagonists. In this field several different classes of compounds, possessing very good affinity (nM range) and with a broad range of selectivity, have been proposed. Recently, our group synthesized a new series of pyrazolo-triazolo-pyrimidines bearing different substitutions at the N-5 and N-8 positions, which have been described as highly potent and selective human A(3) adenosine receptor antagonists. The present review summarizes available data and provides an overview of the structure-activity relationships found for this class of human A(3) adenosine receptor antagonists.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 33 条
[1]   Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists:: Influence of the chain at the N8 pyrazole nitrogen [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Spalluto, G ;
Moro, S ;
Klotz, KN ;
Leung, E ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4768-4780
[2]  
Baraldi PG, 2000, MED RES REV, V20, P103, DOI 10.1002/(SICI)1098-1128(200003)20:2<103::AID-MED1>3.0.CO
[3]  
2-X
[4]   Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A2A and A3 adenosine receptors antagonists [J].
Baraldi, PG ;
Fruttarolo, F ;
Tabrizi, MA ;
Preti, D ;
Romagnoli, R ;
El-Kashef, H ;
Moorman, A ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1229-1241
[5]   Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20:: the first high affinity radioligand antagonist for the human A3 adenosine receptors [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Varani, K ;
Merighi, S ;
Gessi, S ;
Borea, PA ;
Leung, E ;
Hickey, SL ;
Spalluto, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (03) :209-211
[6]   Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: A possible template for adenosine receptor subtypes? [J].
Baraldi, PG ;
Cacciari, B ;
Borea, PA ;
Varani, K ;
Pastorin, G ;
Da Ros, T ;
Tabrizi, MA ;
Fruttarolo, F ;
Spalluto, G .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (26) :2299-2332
[7]   7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists:: A study on the importance of modifications at the side chain on the activity and solubility [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Spalluto, G ;
Monopoli, A ;
Ongini, E ;
Varani, K ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (01) :115-126
[8]   Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor ligands:: A starting point for searching A2B adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Klotz, KN ;
Spalluto, G ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
DRUG DEVELOPMENT RESEARCH, 2001, 53 (2-3) :225-235
[9]   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Spalluto, G ;
Pastorin, G ;
Da Ros, T ;
Klotz, KN ;
Varani, K ;
Gessi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :770-780
[10]   SYNTHESIS OF NEW PYRAZOLO[4,3-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE AND 1,2,3-TRIAZOLO[4,5-E]1,2,4-TRIAZOLO[1,5-C] PYRIMIDINE DISPLAYING POTENT AND SELECTIVE ACTIVITY AS A(2A) ADENOSINE RECEPTOR ANTAGONISTS [J].
BARALDI, PG ;
MANFREDINI, S ;
SIMONI, D ;
ZAPPATERRA, L ;
ZOCCHI, C ;
DIONISOTTI, S ;
ONGINI, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) :2539-2544